logo






US News Digest


US News Digest

President Biden Tests Positive for COVID-19

President Joe Biden tested positive for COVID-19 on Wednesday, the White House announced. The president, who was delivering speeches in Las Vegas, is experiencing mild symptoms and will self-isolate at his home in Delaware. Biden’s doctor reported that the president came down with a runny nose and a non-productive cough on Wednesday afternoon. He was administered the first dose of Paxlovid and will continue to carry out his duties while in isolation.

This is not the first time Biden has contracted the virus; he previously tested positive in July 2022. The latest diagnosis comes amid mounting pressure from fellow Democrats to withdraw from the presidential race against Republican nominee Donald Trump. Despite this, Biden has repeatedly rejected calls to step aside, defending his physical and mental health.

Economic Developments Ahead of Presidential Debate

The upcoming week is expected to be eventful, with a focus on the debate between President Joe Biden and former President Donald Trump. In the economic sphere, market analysts and economists will closely monitor updates on the personal consumption expenditures price index, which is projected to show a decrease both monthly and annually, indicating a potential downturn in price hikes. Additionally, reports on home prices, new home sales, consumer confidence, and GDP growth will provide insights into the economy’s momentum.

Trump has proposed various economic measures, including granting green cards to immigrants who achieve a college degree, exempting tips from income taxation, and prolonging tax reductions initiated in 2017. Biden, on the other hand, is expected to propose tax hikes for individuals earning above $400,000 annually, increased allocations for social welfare programs, and enhanced backing for domestic manufacturing projects and sustainable energy initiatives.

New Alzheimer’s Medication Authorized

A novel drug named Kisunla, manufactured by Eli Lilly, has gained approval as a recent addition to a fresh category of therapies that may moderately decelerate cognitive deterioration in the initial phases of Alzheimer’s disease. Despite posing potential safety hazards, this breakthrough medication offers optimism for managing the epidemic affecting dairy cows.

Researchers suggest that outcomes from a limited trial offer hope that the disease could potentially be managed. This development comes as part of ongoing efforts to combat the virus’s ongoing mutations, with the CDC encouraging the public to undergo annual immunizations.

Impact of Election Uncertainties on Economy

Election uncertainties are expected to dampen capital expenditures, despite favorable financial conditions supporting lucrative investment prospects and deal activities. EY Chief Economist Gregory Daco emphasized the need for caution among consumers and businesses amidst rising costs and interest rates. He anticipates a scenario where modest income growth prompts lower- and middle-income households to scale back spending due to persistent price levels and increased credit expenses.

Daco highlighted May as a turning point for the US economy, signaling a potential slowdown in economic activity. This comes as analysts predict multiple interest rate cuts this year, with the market foreseeing at least two cuts.

Upcoming Debate and Its Implications

The upcoming debate between President Joe Biden and former President Donald Trump is expected to be intense, with both candidates facing pressure to perform well. Biden has come under mounting pressure from fellow Democrats to withdraw from the race, while Trump is seeking to capitalize on Biden’s recent debate performance.

The debate is likely to focus on key issues such as the economy, healthcare, and foreign policy. The outcome of the debate will have significant implications for the presidential race, with both candidates seeking to gain an edge over their opponent.

Check out Today’s Amazon Product Recommendation Here

Support us on Patreon Here

Please contact us here.

© 2024 Sapier. All rights reserved. Link to Sapier.



Leave a Reply

Your email address will not be published. Required fields are marked *